Lv2
158 积分 2025-12-03 加入
Standard chemoradiotherapy with concurrent and adjuvant camrelizumab in patients with high risk nasopharyngeal carcinoma: multicentre, randomised, open label, phase 3 trial
15天前
已完结
Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial
15天前
已完结
Neoadjuvant and adjuvant toripalimab for locoregionally advanced nasopharyngeal carcinoma: a randomised, single-centre, double-blind, placebo-controlled, phase 2 trial
15天前
已完结
Adjuvant PD-1 Blockade With Camrelizumab for Nasopharyngeal Carcinoma: The DIPPER Randomized Clinical Trial
15天前
已完结
Toripalimab Combination Therapy Without Concurrent Cisplatin for Nasopharyngeal Carcinoma: The DIAMOND Randomized Clinical Trial
15天前
已完结
Randomized Phase II Trial of Consolidation Pembrolizumab After Definitive Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma: KCSG HN19-09, CONPELAN Study
15天前
已完结
Automatic Segmentation Of Nasopharyngeal Carcinoma On MR Images: A Single-Institution Experience
3个月前
已完结
PO-1668: Can we use cascade deep learning for GTV delineation in adaptive radiotherapy for NPC?
3个月前
已关闭
2766: Automatic segmentation method for OARs and GTVs delineation for nasopharyngeal carcinoma treatments
3个月前
已关闭
Automatic Segmentation Of Nasopharyngeal Carcinoma On MR Images: A Single-Institution Experience
3个月前
已完结
皖公网安备34019202002308
